Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

Posted on Posted in Uncategorized, Zyloprim and Allopurinol

By Deborah Levenson Be careful when prescribing allo¬¨purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels […]

FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol

Posted on Posted in Zyloprim and Allopurinol

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]

Gout Flare Common Following Allopurinol Discontinuation

Posted on Posted in Zyloprim and Allopurinol

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.   Gout¬†flare is almost 14-times more likely to develop in hospitalized patients who have allopurinol discontinued upon admission compared to those who have the treatment continued, according to new study findings. The findings, presented […]